跳至主要内容
临床试验/ACTRN12610001061022
ACTRN12610001061022已完成3 期

The effect of intranasal oxytocin on alcohol cravings and withdrawal in patients diagnosed with alcohol dependence

niversity of Sydney0 个研究点目标入组 35 人开始时间: 2010年12月2日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • Primary diagnosis of alcohol dependence according to the Diagnostic and Statistical Manual of Mental Disorders (DSM) Edition 4.

排除标准

  • Severe depression with suicidal thoughts and/ or actions
  • Other primary drug addiction (other than nicotine, or cannabis)
  • Not stable on psychotropic medication (i.e., have been taking the medication for less than 4 weeks)
  • Currently receiving psychological or pharmacological treatment for substance use problems
  • Kidney Disease- (i.e., kidney stones, recurrent bladder infections, or known kidney failure).
  • Severe liver disease (e.g., decompensated hepatic failure)
  • Sensitivity to preservatives (in particular E 216, E 218 and chlorobutanol hemihydrate).
  • Nasal obstruction, discharge, or bleeding
  • Cardiovascular problems (e.g., heart disease, history of heart attacks), high blood pressure (hypertension)
  • Habitually drink large volumes of water

研究者

相似试验